Share this via
Sensex, Nifty, Share Prices LIVE: The stock of Concord Biotech has been in a sideways trend so far this week after losing nearly 13 per cent last week. It is now consolidating above a strong support band of ₹1,750-1,775. We expect the stock to gain positive momentum on the back of this and see a rally in the short term. The initial rebound can take the stock to ₹1,960, a minor hurdle. Around this price point, there might be some sideways crawl or a minor dip to ₹1,920. After this, the stock can see a rally to ₹2,140. So, traders can buy the stock now at ₹1,797 and ₹1,760. Stop-loss can be ₹1,720.
Banks holiday will be observed today in some parts of India on the account of Rath Yatra and Kang festival.
JSW Paints will acquire a 74.76% stake in Akzo Nobel India (ANIL) from Akzo Nobel NV for up to Rs 8,986 crores. The deal, pending regulatory approval and a tender offer, brings brands like Dulux into the JSW fold. JSW aims to build the ...more
The Karnataka government has reversed its decision to double the liquor excise license renewal fees
The GMP of the HDB Financial Services IPO is 8.11% today.
At 9.53 am on Friday, September Brent oil futures were at $67.14, up by 0.67% and August crude oil futures on WTI were at $65.66, up by 0.64%
Wakefit reported total income of ₹1,000 crore for FY24, with revenue growing at 24.87% CAGR from FY22 to FY24
The GMP of the Sambhv Steel Tubes IPO currently stands at 13.41%, indicating mild listing gains.
A rise in global crude oil prices and a slightly stronger greenback capped further gains in the local unit
In Asian markets, Japan's Nikkei 225 index traded higher while South Korea's Kospi, Shanghai's SSE Composite index and Hong Kong's Hang Seng were quoting lower.
Those leaving the committee include high-profile veterans such as ex-CEO Daniel Zhang, co-founder Lucy Peng and former CFO Maggie Wu, part of an old guard who helped build Alibaba
Get over your FOMO of knowing what's happening. Never miss what matters to you!
